placeholder image
A. L. Peters All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial. 
    JAMA network open. 2025
  • Glycaemic outcomes in adults with type 2 diabetes over 34鈥墂eeks with the Omnipod庐 5 Automated Insulin Delivery System. 
    Diabetes, Obesity & Metabolism. 2025
  • Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens. 
    Diabetes Technology & Therapeutics. 2024
  • The Diabetes Technology Society error grid and trend accuracy matrix for glucose monitors. 
    Journal of Diabetes Science and Technology. 2024
  • Increased derived time in range is associated with reduced risk of major adverse cardiovascular events, severe hypoglycemia, and microvascular events in type 2 diabetes: a post hoc analysis of DEVOTE. 
    Diabetes Technology & Therapeutics. 2023
  • Safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes: from injections to hybrid closed-loop therapy. 
    Diabetes care. 2023
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • Safety and tolerability of high-dose daily vitamin D(3) supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetes. 
    European Journal of Clinical Nutrition. 2022
  • Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 
    JAMA. 2021
  • Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data. 
    Diabetes, Obesity & Metabolism. 2021
  • Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM Study. 
    Journal of Diabetes Science and Technology. 2021
  • The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 
    Diabetes care. 2021
  • Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. 
    Diabetologia. 2020
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. 
    Journal of Clinical Endocrinology and Metabolism. 2019
  • Vitamin D supplementation and prevention of type 2 diabetes. 
    New England Journal of Medicine. 2019
  • Baseline characteristics of the Vitamin D and type 2 Diabetes (D2d) study: a contemporary prediabetes cohort that will inform diabetes prevention efforts. 
    Diabetes care. 2018
  • REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 
    Diabetes care. 2017
  • Hypoglycemia in older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2016
  • Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. 
    Diabetes care. 2016
  • Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study. 
    BMJ open diabetes research & care. 2015
  • Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. 
    Diabetologia. 2015
  • Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. 
    Diabetes care. 2015
  • Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. 
    Diabetologia. 2015
  • Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. 
    Diabetes care. 2015
  • Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. 
    Diabetes care. 2015
  • Depression in adults in the T1D Exchange Clinic Registry. 
    Diabetes care. 2014
  • Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. 
    Diabetes care. 2014
  • Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. 
    Journal of Clinical Endocrinology and Metabolism. 2013
  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
    Diabetologia. 2012
    • Review
  • Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association [review]. 
    Diabetologia. 2023
  • Biomarkers for the diagnosis of heart failure in people with diabetes: a consensus report from Diabetes Technology Society [review]. 
    Progress in Cardiovascular Diseases. 2023
  • Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association [review]. 
    Diabetes care. 2022
  • Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group [review]. 
    Diabetes care. 2020
  • Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [review]. 
    Diabetologia. 2017
  • Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [review]. 
    Diabetes care. 2017
  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [review]. 
    Diabetes care. 2012
  • Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM) [review]. 
    Diabetes Technology & Therapeutics. 2008
    • Abstract
  • Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P]. 
    Diabetes. 2015
    • Contact
    full name
  • A. L. Peters
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration